Abstract
Purpose of the study is to evaluate the intraocular pressure (IOP) lowering effect and ocular side effects of Daunorubicin (DNR) in drug modulated trabeculectomy.
Method: A prospective study was conducted on 50 eyes of 49 patients. Only primary open angle cases were taken up for the study. These were randomly divided into equal groups. Group I underwent modified trabeculectomy with application of 0.2mg/ml of Daunorubicin (DNR) intra operatively. Group II underwent conventional trabeculectomy, patients were followed for six months. Parameter including visual acuity , IOP by NCT/ shiotz, slit lamp examination were performed on every visit. An IOP of 21mg Hg or less were taken as criteria for success.
Results: 48% of the patients were males and 52% females. The visual acuity was maintained at preoperative levels for all cases except two in which it improved from 6/24 top 6/18 in group I and deteriorated from 6/9 to 6/18 in one patient in group II. The final mean IOP at 24 weeks was 14.23 + 4.94 mm Hg in group I and 16.2 + 5.07 mm Hg in group II. A success rate of 92% (IOP < 20mm Hg) was obtained in S/C Daunorubicin versus 84% in group II at 24 weeks.
Conclusion: These results indicate primary trabeculectomy with Daunorcubicin to be associated with 92% success rate and lower mean IOP levels as compared to those undergoing Primary trabeculectomy without adjuvant Daunorubicin.
Keywords: Trabeculectomy, Daunorubicin, Intraocular Pressure (IOP).
References
- Ramakrishnan, Mona Khurana: Surgical Management of Glaucoma; An Indian perspective., Indian journal of Ophthalmology (2011)
- Cairns JE. Trabeculectomy : preliminary report of a new method. Am J Ophthalmol 1968; 66: 673-679
- MR Chang , Q.I. Cheng. DA LEE; Journal of ocular pharmacology -1998 libertpub.com
- Lee DA, Lee TC, Cortes AE, Kitada S. Effect of mithramycin, mitomycin, daunorubicin and bleomycin of human subconjuctival fibroblast attachment and proliferation. Invest Ophthalmol Vis Sci 1990; 31 (10):2136-2144
- Dadeya S, Kamlesh MS, Khurana C, Fatima S. Intraoperative daunorubicin in strabismus surgery. J Pediatr ophthalmol Strabismus 2002; 39(6) : 340-344.
- Dadeya S, Kamlesh MS, Khurana C, Fatima S. Intraoperative daunorubicin versus conjunctival autograft in primary pterygium surgery. Cornea 2002; 21(8): 766-769.
- Kumar A, Nainiwal S, Choudhary I, Tewari HK, Verma LK. Role of daunorubicin in inhabiting proliferative vitreoretinopathy after retinal detachment surgery. Clin Exp Ophthalmol 2002; 30(5): 348.
- Aggarwal , HC et al. Efficacy and safety of Daunorubicin in Glaucoma Filtration surgery .Indian ophthalmology , 1997.
- Jasleen et al : Low Dose Daunorubicin as an adjuvant in glaucoma filtration surgery M. S. Thesis. MAMC, Delhi 1998.
- Morales J, Kelleher PJ, Campbell D, Crosson CE. Effect of daunomycin implants on filtering surgery outcomes in rabbit. Curr Eye Res 1998; 17 (8): 844-850
- Borisuth NS, Phillips B, Krupin T. The risk profile of glaucoma filtration surgery. Curr Opin Ophthalmol 1999; 10 (2): 112-116.
- Jampel HD, Pasquale LR, Diebeinaido C. Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol 1992; 100: 1049-1080
- Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with motomycin-C. Am j Ophthalmol 1993; 116 (3): 314-326.
- Gill R S, Shefali, Kaur G: Daunorubicin- A new alternative in recalcitrant glaucoma filtering surgery. All India Ophthalm-ogical Society Abstract 56th Annual Conference 1998; 90.
- Verma, R Sihote and HC Aggarwal : Evaluation and safety of Daunorubicin in glaucoma filtering surgery eye. (2007) 21, 784-788.
- Demailly P, Kretz G. Daunorubicin versus 5-fluorouracil in surgical treatment of primary open angle glaucoma: a prospective study . Int Ophthalmol 1992; 16(4-5): 367-370.
- Rabowsky JH, Dukes AJ, Lee DA, Leong KW. The use of bioerodible polymers and Daunorubicin in glaucoma filtering surgery. Ophthalmology 1996; 103 (5): 800-807.
Corresponding Author
Dr Sarabjit Singh
Prof. of Surgery Govt. Medical College Jammu
Add: 37 B/C Gandhi Nagar Jammu -180007 India
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
DOI: https://dx.doi.org/10.18535/jmscr/v7i2.82
